Home Companies Catalysts Deep Dives

ADHD

ADHD · Neurology · 2 drugs · 2 indications

Competitive Landscape (2 drugs)
DrugCompanyMechanismModalityRouteStage
Centanafadine4578Triple Reuptake Inhibitor (NDSRI)Small moleculeORALFILED
Vyvanse—Prodrug CNS stimulantSmall moleculePOAPPROVED
Indications (2)
ADHD
Vyvanse APPROVED
ADHD, children/adolescents/adults
Centanafadine FILED
Upcoming Catalysts
Centanafadine - ADHD - FDA PDUFA DecisionREGULATORY
4578July 24, 2026
Data from Supabase · Updated 2026-03-24